Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

We’re working to bring the hope of advanced medicine to more patients.

Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

The most lethal strain could be eliminated by 2030, but major hurdles remain.

Explaining Chagas disease through the stories of patients in Bolivia.

Jennifer Allport-Anderson hunts for cardiac cures.